Should all patients (pts) with advanced biliary cancers receive first-line treatment with cisplatin and gemcitabine (GC)?

Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPMIRANDA, Vanessa CostaDIB-FARIA, LuizaBRAGHIROLI, Maria Ignez Freitas MelroSABBAGA, JorgeSARAGIOTTO, Daniel FernandesCASTRO, GilbertoHOFF, Paulo M.RIECHELMANN, Rachel2014-07-182014-07-182013JOURNAL OF CLINICAL ONCOLOGY, v.31, n.4, suppl.S, 20130732-183Xhttps://observatorio.fm.usp.br/handle/OPI/6307engopenAccessShould all patients (pts) with advanced biliary cancers receive first-line treatment with cisplatin and gemcitabine (GC)?conferenceObjectCopyright AMER SOC CLINICAL ONCOLOGYOncology1527-7755